"Never doubt that a small group of thoughtful, committed citizens can change the world. Indeed, it is the only thing that ever has."

Margaret Mead
Case report
peer-reviewed

Integration of Stereotactic Ablative Radiotherapy in the Management of Pulmonary Metastases from Salivary Adenoid Cystic Carcinoma



Abstract

In this teaching case, we use the example of a woman with pulmonary metastases from a parotid gland adenoid cystic carcinoma (ACC) to illustrate the optimal use of stereotactic ablative body radiotherapy (SABR) in the context of other aggressive treatment options.



Want to read more?

Create a free account to continue reading this article.

Already a member? Login.



Case report
peer-reviewed

Integration of Stereotactic Ablative Radiotherapy in the Management of Pulmonary Metastases from Salivary Adenoid Cystic Carcinoma


Author Information

George Rodrigues Corresponding Author

Department of Radiation Oncology, London Regional Cancer Program, London, Ontario, CA; Schulich School of Medicine & Dentistry, Western University, London, Ontario, CA

Tyler Kaster

University of Ottawa


Ethics Statement and Conflict of Interest Disclosures

Human subjects: Consent was obtained by all participants in this study. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.


Case report
peer-reviewed

Integration of Stereotactic Ablative Radiotherapy in the Management of Pulmonary Metastases from Salivary Adenoid Cystic Carcinoma


Figures etc.

Share
Case report
peer-reviewed

Integration of Stereotactic Ablative Radiotherapy in the Management of Pulmonary Metastases from Salivary Adenoid Cystic Carcinoma

  • Author Information
    George Rodrigues Corresponding Author

    Department of Radiation Oncology, London Regional Cancer Program, London, Ontario, CA; Schulich School of Medicine & Dentistry, Western University, London, Ontario, CA

    Tyler Kaster

    University of Ottawa


    Ethics Statement and Conflict of Interest Disclosures

    Human subjects: Consent was obtained by all participants in this study. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.

    Acknowledgements


    Article Information

    Published: January 09, 2014

    DOI

    10.7759/cureus.154

    Cite this article as:

    Rodrigues G, Kaster T (January 09, 2014) Integration of Stereotactic Ablative Radiotherapy in the Management of Pulmonary Metastases from Salivary Adenoid Cystic Carcinoma. Cureus 6(1): e154. doi:10.7759/cureus.154

    Publication history

    Received by Cureus: December 27, 2013
    Peer review began: December 30, 2013
    Published: January 09, 2014

    Copyright

    © Copyright 2014
    Rodrigues et al. This is an open access article distributed under the terms of the Creative Commons Attribution License CC-BY 3.0., which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

    License

    This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Abstract

In this teaching case, we use the example of a woman with pulmonary metastases from a parotid gland adenoid cystic carcinoma (ACC) to illustrate the optimal use of stereotactic ablative body radiotherapy (SABR) in the context of other aggressive treatment options.



Want to read more?

Create a free account to continue reading this article.

Already a member? Login.